(Alliance News) - GSK PLC on Monday said Exdensur has been approved in the UK, for the treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps. Read More
(Alliance News) - AstraZeneca PLC on Monday said enhertu plus pertuzumab has been approved in the US as a first-line treatment of patients with HER2-positive metastatic breast cancer. Read More
Aquila European Renewables PLC - managed by Aquila Capital, invests in European renewable energy assets - Completes EUR36.6 million sale of Danish assets Holmen II and Svindbaek. The disposal of Greek asset Desfina is expected to complete in February. Together with the sale of Sagres, which completed in June, the disposals total EUR78.3 million. Overall, Aquila continues to progress the divestment of the remainder of its portfolio as part of the managed wind-down. By late January, expects an initial return of capital of no less than EUR33.9 million, representing the majority of proceeds received from the disposals in 2025, excluding a cash buffer to ensure Aquila can meet its liabilities and commitments. Combined with the EUR2.5 dividend declared on November 24 and the proceeds of the Greek disposal, the amount is equivalent to the EUR63.0 million announced on October 23. Additionally, determines that a B share scheme is the most cost-efficient and flexible means of returning capital to shareholders. The B share scheme is subject to approval at its annual general meeting on January 8. Read More
(Alliance News) - GreenRoc Strategic Materials PLC said on Monday that its Danish subsidiary, GreenRoc DK a/s, has been granted government funding for a proposed graphite project. Read More
(Alliance News) - Chariot Ltd on Monday said it completed a financing and strategic equity partnership established primarily to fund its investment in two wind generation projects in South Africa, which also reached financial close on Monday. Read More
(Alliance News) - Watkin Jones PLC on Monday said it has agreed to add a high-quality purpose-built student accommodation development opportunity in Bristol into its joint venture with Maslow Capital. Read More
(Alliance News) - The FTSE 100 marched higher on Monday, ahead of a raft of key economic data and an expected interest rate cut by the Bank of England later this week. Read More
(Alliance News) - Amedeo Air Four Plus Ltd on Monday reported a lower interim net asset value but swung to a profit from a loss, and said it will need to start preparing the redelivery of two aircraft in the absence of an Emirates agreement. Read More
(Alliance News) - Adsure Services PLC reported slightly decreased profit and revenue for its first six months, but said it "consolidated its growth" and is well-positioned for the full year. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The UK's independent accounting regulator on Monday said it has launched an investigation into Ernst & Young LLP's audit of Shell PLC over a potential breach of audit partner rotation rules. Read More
(Alliance News) - The UK housing market performed broadly in line with expectations over the last year, while property prices are anticipated to climb modestly in 2026, Halifax said Monday. Read More
(Alliance News) - Beeks Financial Cloud Group PLC on Monday said it has signed a multi-year Exchange Cloud contract with nuam SA, the holding company that integrates the stock exchanges of Chile, Colombia and Peru. Read More
InterContinental Hotels Group PLC - Windsor, England-based hotel company - Appoints Nicholas Cadbury as non-executive director. Cadbury is currently chief financial and sustainability officer of International Consolidated Airlines Group SA. He was previously group finance director at Whitbread PLC from 2012 to 2022. The appointment will be effective from March 1, 2026. He will serve on the audit and responsible business committees upon appointment. Read More
Porvair PLC - Norfolk, England-based environmental and specialist filtration technology firm - Estimates operating profit and margins for the financial year that ended November 30 to come in ahead of the prior year, with adjusted earnings per share set to be marginally above market expectations. Porvair expects revenue to grow by around 1%, or 2% at constant currency. It had net cash of GBP23 million at the financial year-end, up 68% from GBP13.7 million a year earlier. Full annual results will be published on February 9. Read More